Evidence map›Paper›PMID 41796330›Full record

ArticleJournal of translational medicine2026

Medicine digital transformation: evidence from Chinese physicians on generative artificial intelligence implementation and challenges.

Anqi Lin, Meiyuan Zeng, Wenyi Gan, Aimin Jiang, Yukang Liu, Chang Qi, Lingxuan Zhu, Weiming Mou, Dongqiang Zeng, Mingjia Xiao and 10 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Anqi Lin *Department of Oncology, Zhujiang Hospital, Southern Medical University; Donghai County People's Hospital, Affiliated Kangda College of Nanjing Medical University, 222000, Lianyungang, China.
Meiyuan Zeng *Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
Wenyi Gan *Department of Joint Surgery and Sports Medicine, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Guangdong, China.
Aimin Jiang *Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
Yukang LiuDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
Chang QiInstitute of Logic and Computation, TU Wien, Austria.
Lingxuan ZhuDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
Weiming MouDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
Dongqiang ZengClinical Innovation and Research Centre (CIRC), Shenzhen Hospital of Southern Medical University, Shenzhen, 518101, China.
Mingjia XiaoHepatobiliary Surgery Department, Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
Guangdi ChuDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Shengkun PengDepartment of Radiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China.
Hank Z H WongLi Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Lin ZhangThe School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3000, Australia.
Hengguo ZhangCollege & Hospital of Stomatology, Anhui Medical University, Key Lab. of Oral Diseases Research of Anhui Province, Hefei, 230032, China.
Xinpei DengDepartment of Urology, State Key Laboratory of Oncology in Southern China, Sun Yat-Sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, 510060, China.
Jian ZhangDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
Quan ChengDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. chengquan@csu.edu.cn.
Bufu TangDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. tangbufu@zju.edu.cn.
Peng LuoDepartment of Oncology, Zhujiang Hospital, Southern Medical University; Donghai County People's Hospital, Affiliated Kangda College of Nanjing Medical University, 222000, Lianyungang, China. luopeng@smu.edu.cn.ORCID http://orcid.org/0000-0002-8215-2045

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveArtificial intelligence (AI) technology is profoundly transforming the healthcare domain, with generative artificial intelligence (GenAI) and AI chatbots demonstrating significant potential across clinical practice, medical research, and medical education through their robust data generation and personalized interaction capabilities. However, systematic research on how Chinese physicians apply these advanced technologies remains limited, highlighting a critical need to explore real-world application patterns and multidimensional challenges of GenAI technology in medicine from physicians’ perspectives. This study aims to provide empirical evidence for the rational application and responsible governance of GenAI in the Chinese healthcare system, thereby advancing global understanding of AI integration in medicine. MATERIALS AND

methodsThis study employed a cross-sectional survey design targeting licensed physicians in China, and data were collected through standardized anonymous electronic questionnaires. To ensure study comprehensiveness and scientific rigor, we systematically reviewed relevant literature to inform questionnaire development. The literature search encompassed studies published between January 2018 and February 2024 indexed in PubMed, Web of Science, and Google Scholar. The questionnaire assessed respondents’ demographic characteristics, current applications of AI chatbots in clinical practice, medical research, and medical education, as well as physicians’ attitudes toward AI chatbots and their perceived potential challenges.

resultsResults revealed that physicians who had used AI chatbots generally held positive attitudes, while non-users demonstrated significantly more cautious attitudes. Physicians primarily expressed concerns regarding information reliability in AI chatbot application, compliance with relevant academic ethical standards, and possible impacts on critical thinking development among medical professionals. These findings collectively depict an overall attitude toward GenAI in the Chinese medical context that is both enthusiastic and cautious.

conclusionsThis study represents one of the few empirical investigations on Chinese physicians’ use of GenAI, with both academic and practical significance. The research findings provide valuable insights into the practical application of GenAI in the Chinese healthcare system and offer evidence-based support for technology optimization, application strategy development, and establishment of systematic risk mitigation mechanisms.

Indexed as

Artificial IntelligenceGenerative Artificial IntelligencePhysiciansAdultAttitude of Health PersonnelChinaCross-Sectional StudiesDigital HealthFemaleHumansMaleMiddle AgedSurveys and QuestionnairesAI-chatbotsArtificial intelligenceChinese physiciansElectronic surveyGenerative artificial intelligence

Identifiers

PMID41796330
PMCPMC13081645

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.